METHOD FOR PREVENTING CARDIO-VASCULAR DISEASES IN WOMEN AT CLIMACTERIC PERIOD AT THE BACKGROUND OF SUBSTITUTE HORMONAL THERAPY
FIELD: medicine. ^ SUBSTANCE: before applying substitute hormonal therapy (SHT) on should evaluate antithrombogenic activity of vascular wall in women. For this purpose one should determine quantitative values of ADP-induced aggregation of thrombocytes, activity of antithrombin III in blood and fibr...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; rus |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BUBNOVA G.V BULGAKOV R.V KRAVTSOV N.G LOBANOVA E.G ZAJTSEVA T.A FIRSOVA T.A JAKUSHEVA E.G ISHCHENKO A.I STEPANKOVA I.M LANCHINSKIJ V.I POPKOVA A.M GAL'TSOVA N.E MALINOV O.A POPKOV S.A SHPACHENKO V.V KOVALEV M.I |
| description | FIELD: medicine. ^ SUBSTANCE: before applying substitute hormonal therapy (SHT) on should evaluate antithrombogenic activity of vascular wall in women. For this purpose one should determine quantitative values of ADP-induced aggregation of thrombocytes, activity of antithrombin III in blood and fibrinolytic blood activity both before and after "cuff"-test. Then one should detect the indices calculated as the ratio of mentioned values both before and after carrying out the mentioned test. If mentioned indices are decreased against the norm by 20-40% women should be prescribed to undergo SHT at additional introduction of aspirin and supradin. The method provides prophylaxis of cardio-vascular diseases in this category of female patients due to correcting affected functional activity of vascular endothelium. ^ EFFECT: higher efficiency of prophylaxis. ^ 1 cl, 1 ex, 4 tbl |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2246249C1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2246249C1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2246249C13</originalsourceid><addsrcrecordid>eNqNjDEKwkAQRdNYiHqHuUAKowiWk91JspjshtnZiFUIslaigVh7diN4AJv_4PH4y-TdkFROQ-EYWqaOrBhbgkLWxqUdehVqZNDGE3ryYCycXUMWUEDVpkElxEZBO-98M1upCHJUp5JdsBpcAT7kXowEIagcN85i_a0Y28s6WdyG-xQ3P64SKEhUlcbx2cdpHK7xEV89hyzbH7L9UW13fyQfjvk7gw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD FOR PREVENTING CARDIO-VASCULAR DISEASES IN WOMEN AT CLIMACTERIC PERIOD AT THE BACKGROUND OF SUBSTITUTE HORMONAL THERAPY</title><source>esp@cenet</source><creator>BUBNOVA G.V ; BULGAKOV R.V ; KRAVTSOV N.G ; LOBANOVA E.G ; ZAJTSEVA T.A ; FIRSOVA T.A ; JAKUSHEVA E.G ; ISHCHENKO A.I ; STEPANKOVA I.M ; LANCHINSKIJ V.I ; POPKOVA A.M ; GAL'TSOVA N.E ; MALINOV O.A ; POPKOV S.A ; SHPACHENKO V.V ; KOVALEV M.I</creator><creatorcontrib>BUBNOVA G.V ; BULGAKOV R.V ; KRAVTSOV N.G ; LOBANOVA E.G ; ZAJTSEVA T.A ; FIRSOVA T.A ; JAKUSHEVA E.G ; ISHCHENKO A.I ; STEPANKOVA I.M ; LANCHINSKIJ V.I ; POPKOVA A.M ; GAL'TSOVA N.E ; MALINOV O.A ; POPKOV S.A ; SHPACHENKO V.V ; KOVALEV M.I</creatorcontrib><description>FIELD: medicine. ^ SUBSTANCE: before applying substitute hormonal therapy (SHT) on should evaluate antithrombogenic activity of vascular wall in women. For this purpose one should determine quantitative values of ADP-induced aggregation of thrombocytes, activity of antithrombin III in blood and fibrinolytic blood activity both before and after "cuff"-test. Then one should detect the indices calculated as the ratio of mentioned values both before and after carrying out the mentioned test. If mentioned indices are decreased against the norm by 20-40% women should be prescribed to undergo SHT at additional introduction of aspirin and supradin. The method provides prophylaxis of cardio-vascular diseases in this category of female patients due to correcting affected functional activity of vascular endothelium. ^ EFFECT: higher efficiency of prophylaxis. ^ 1 cl, 1 ex, 4 tbl</description><edition>7</edition><language>eng ; rus</language><subject>DIAGNOSIS ; HUMAN NECESSITIES ; HYGIENE ; IDENTIFICATION ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SURGERY</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050220&DB=EPODOC&CC=RU&NR=2246249C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050220&DB=EPODOC&CC=RU&NR=2246249C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BUBNOVA G.V</creatorcontrib><creatorcontrib>BULGAKOV R.V</creatorcontrib><creatorcontrib>KRAVTSOV N.G</creatorcontrib><creatorcontrib>LOBANOVA E.G</creatorcontrib><creatorcontrib>ZAJTSEVA T.A</creatorcontrib><creatorcontrib>FIRSOVA T.A</creatorcontrib><creatorcontrib>JAKUSHEVA E.G</creatorcontrib><creatorcontrib>ISHCHENKO A.I</creatorcontrib><creatorcontrib>STEPANKOVA I.M</creatorcontrib><creatorcontrib>LANCHINSKIJ V.I</creatorcontrib><creatorcontrib>POPKOVA A.M</creatorcontrib><creatorcontrib>GAL'TSOVA N.E</creatorcontrib><creatorcontrib>MALINOV O.A</creatorcontrib><creatorcontrib>POPKOV S.A</creatorcontrib><creatorcontrib>SHPACHENKO V.V</creatorcontrib><creatorcontrib>KOVALEV M.I</creatorcontrib><title>METHOD FOR PREVENTING CARDIO-VASCULAR DISEASES IN WOMEN AT CLIMACTERIC PERIOD AT THE BACKGROUND OF SUBSTITUTE HORMONAL THERAPY</title><description>FIELD: medicine. ^ SUBSTANCE: before applying substitute hormonal therapy (SHT) on should evaluate antithrombogenic activity of vascular wall in women. For this purpose one should determine quantitative values of ADP-induced aggregation of thrombocytes, activity of antithrombin III in blood and fibrinolytic blood activity both before and after "cuff"-test. Then one should detect the indices calculated as the ratio of mentioned values both before and after carrying out the mentioned test. If mentioned indices are decreased against the norm by 20-40% women should be prescribed to undergo SHT at additional introduction of aspirin and supradin. The method provides prophylaxis of cardio-vascular diseases in this category of female patients due to correcting affected functional activity of vascular endothelium. ^ EFFECT: higher efficiency of prophylaxis. ^ 1 cl, 1 ex, 4 tbl</description><subject>DIAGNOSIS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>IDENTIFICATION</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SURGERY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjDEKwkAQRdNYiHqHuUAKowiWk91JspjshtnZiFUIslaigVh7diN4AJv_4PH4y-TdkFROQ-EYWqaOrBhbgkLWxqUdehVqZNDGE3ryYCycXUMWUEDVpkElxEZBO-98M1upCHJUp5JdsBpcAT7kXowEIagcN85i_a0Y28s6WdyG-xQ3P64SKEhUlcbx2cdpHK7xEV89hyzbH7L9UW13fyQfjvk7gw</recordid><startdate>20050220</startdate><enddate>20050220</enddate><creator>BUBNOVA G.V</creator><creator>BULGAKOV R.V</creator><creator>KRAVTSOV N.G</creator><creator>LOBANOVA E.G</creator><creator>ZAJTSEVA T.A</creator><creator>FIRSOVA T.A</creator><creator>JAKUSHEVA E.G</creator><creator>ISHCHENKO A.I</creator><creator>STEPANKOVA I.M</creator><creator>LANCHINSKIJ V.I</creator><creator>POPKOVA A.M</creator><creator>GAL'TSOVA N.E</creator><creator>MALINOV O.A</creator><creator>POPKOV S.A</creator><creator>SHPACHENKO V.V</creator><creator>KOVALEV M.I</creator><scope>EVB</scope></search><sort><creationdate>20050220</creationdate><title>METHOD FOR PREVENTING CARDIO-VASCULAR DISEASES IN WOMEN AT CLIMACTERIC PERIOD AT THE BACKGROUND OF SUBSTITUTE HORMONAL THERAPY</title><author>BUBNOVA G.V ; BULGAKOV R.V ; KRAVTSOV N.G ; LOBANOVA E.G ; ZAJTSEVA T.A ; FIRSOVA T.A ; JAKUSHEVA E.G ; ISHCHENKO A.I ; STEPANKOVA I.M ; LANCHINSKIJ V.I ; POPKOVA A.M ; GAL'TSOVA N.E ; MALINOV O.A ; POPKOV S.A ; SHPACHENKO V.V ; KOVALEV M.I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2246249C13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2005</creationdate><topic>DIAGNOSIS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>IDENTIFICATION</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SURGERY</topic><toplevel>online_resources</toplevel><creatorcontrib>BUBNOVA G.V</creatorcontrib><creatorcontrib>BULGAKOV R.V</creatorcontrib><creatorcontrib>KRAVTSOV N.G</creatorcontrib><creatorcontrib>LOBANOVA E.G</creatorcontrib><creatorcontrib>ZAJTSEVA T.A</creatorcontrib><creatorcontrib>FIRSOVA T.A</creatorcontrib><creatorcontrib>JAKUSHEVA E.G</creatorcontrib><creatorcontrib>ISHCHENKO A.I</creatorcontrib><creatorcontrib>STEPANKOVA I.M</creatorcontrib><creatorcontrib>LANCHINSKIJ V.I</creatorcontrib><creatorcontrib>POPKOVA A.M</creatorcontrib><creatorcontrib>GAL'TSOVA N.E</creatorcontrib><creatorcontrib>MALINOV O.A</creatorcontrib><creatorcontrib>POPKOV S.A</creatorcontrib><creatorcontrib>SHPACHENKO V.V</creatorcontrib><creatorcontrib>KOVALEV M.I</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BUBNOVA G.V</au><au>BULGAKOV R.V</au><au>KRAVTSOV N.G</au><au>LOBANOVA E.G</au><au>ZAJTSEVA T.A</au><au>FIRSOVA T.A</au><au>JAKUSHEVA E.G</au><au>ISHCHENKO A.I</au><au>STEPANKOVA I.M</au><au>LANCHINSKIJ V.I</au><au>POPKOVA A.M</au><au>GAL'TSOVA N.E</au><au>MALINOV O.A</au><au>POPKOV S.A</au><au>SHPACHENKO V.V</au><au>KOVALEV M.I</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD FOR PREVENTING CARDIO-VASCULAR DISEASES IN WOMEN AT CLIMACTERIC PERIOD AT THE BACKGROUND OF SUBSTITUTE HORMONAL THERAPY</title><date>2005-02-20</date><risdate>2005</risdate><abstract>FIELD: medicine. ^ SUBSTANCE: before applying substitute hormonal therapy (SHT) on should evaluate antithrombogenic activity of vascular wall in women. For this purpose one should determine quantitative values of ADP-induced aggregation of thrombocytes, activity of antithrombin III in blood and fibrinolytic blood activity both before and after "cuff"-test. Then one should detect the indices calculated as the ratio of mentioned values both before and after carrying out the mentioned test. If mentioned indices are decreased against the norm by 20-40% women should be prescribed to undergo SHT at additional introduction of aspirin and supradin. The method provides prophylaxis of cardio-vascular diseases in this category of female patients due to correcting affected functional activity of vascular endothelium. ^ EFFECT: higher efficiency of prophylaxis. ^ 1 cl, 1 ex, 4 tbl</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; rus |
| recordid | cdi_epo_espacenet_RU2246249C1 |
| source | esp@cenet |
| subjects | DIAGNOSIS HUMAN NECESSITIES HYGIENE IDENTIFICATION MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SURGERY |
| title | METHOD FOR PREVENTING CARDIO-VASCULAR DISEASES IN WOMEN AT CLIMACTERIC PERIOD AT THE BACKGROUND OF SUBSTITUTE HORMONAL THERAPY |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T08%3A27%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BUBNOVA%20G.V&rft.date=2005-02-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2246249C1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |